1. PRNewswire.com: Clinical trial provides preliminary evidence of a cure for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long Covid Wow, that's a dramatic headline, isn't it? Let's hope the treatment lives up to the headline! From the press release: "Cortene Inc.

1. AJMC.com: Machine learning algorithm finds links between adverse childhood experiences, rheumatic diseases From the article: “Overall, adverse childhood experiences seem relatively more important than personality traits, psychopathological or demographic variables,” the authors said. “The

1. National Institute for Health and Care Excellence: NICE pauses publication of updated guideline on diagnosis and management of ME/CFS From the press release: "Because of issues raised during the pre-publication period with the final guideline, we need to take time to consider next steps. We

1. Pain News Network: Widespread pain raises risk of dementia and stroke From the article: "While the number of cases was small, researchers found an association between pain and cognitive decline. Participants with widespread pain were 43% more likely to have some type of dementia, 47% more

1. ScienceAlert.com: Chronic pain has 9 distinct types, according to a large new body mapping study From the article: "Using a computer clustering analysis of patient body pain maps and pain assessments, the researchers discovered that patients fit into nine groups of chronic pain. ... What's

Note: It's been a slow week for fibromyalgia and Lyme news, so you'll notice #4 and #5 are older articles. I had saved both articles for my weekly news posts when they published, but just never got around to sharing them ... until now! 1. Pain News Network: Study of fibromyalgia drug continues

1. BusinessWire.com: Virios Therapeutics highlights clinical sites fully operational in phase 2b fibromyalgia study featuring FDA “fast track” review designated antiviral therapy, oral IMC-1 From the article: "Virios Therapeutics, Inc., a clinical-stage biotechnology company focused on

1. NeuroMetrix.com: NeuroMetrix receives FDA breakthrough device designation for treatment of fibromyalgia with its wearable neurostimulation technology From the article: "A total of 119 subjects with fibromyalgia were enrolled and randomized to a standard (active) or modified (sham) Quell